Research Article
Expression, Mutation, and Amplification Status of EGFR and Its Correlation with Five miRNAs in Salivary Gland Tumours
Table 2
Tumour characteristics at diagnosis.
| | Characteristics ( = available data) | Number of
patients (%) |
| | Histological subtype | | | Acinic cell carcinoma (ACCC) | 16 (22.9) | | Mucoepidermoid carcinoma (MEC) | 16 (22.9) | | Carcinoma ex pleomorphic adenoma (Ca ex PA) | 9 (12.9) | | Adenoid cystic carcinoma (ACC) | 8 (11.4) | | Poorly differentiated carcinoma | 7 (10.0) | | Epithelial myoepithelial carcinoma (EMC) | 5 (7.1) | | Adenocarcinoma NOS (ACNOS) | 4 (5.7) | | Salivary duct carcinoma (SDC) | 2 (2.9) | | Small cell carcinoma (SCC) | 1 (1.4) | | Carcinosarcoma | 1 (1.4) | | Adenosquamous carcinoma | 1 (1.4) | | Classification | | | Favourable clinical prognosis | 35 (50.0) | | Poor clinical prognosis | 35 (50.0) | | Tumour size/T stage | | | Tis | 4 (6.0) | | T1 | 15 (22.4) | | T2 | 18 (26.9) | | T3 | 14 (20.9) | | T4 | 16 (23.9) | | Lymph node status/N stage | | | N0 | 45 (70.3) | | N1 | 5 (7.8) | | N2 | 14 (21.9) | | Surgical resection | 59/63 (93.7%) | | Postoperative radiotherapy | 39/63 (61.9%) |
|
|
